ESC 365 - Doctor Sonia Eiras

Speaker illustration

Doctor Sonia Eiras

Health Research Institute, Santiago de Compostela (Spain)

Member of:

Presentations Articles

Semaglutide modulates pro-inflammatory neutrophil phenotype induced by supraphysiological levels of the adipokine FABP4 in patients with cardiovascular disease.

Event: ESC Congress 2024

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Session: Antidiabetic drugs for treatment of cardiovascular disease

Epicardial carbohydrate antigen 125 (CA-125) levels, associated with neutrophils activity in heart failure: No differences regarding sex

Event: ESC Congress 2024

Topic: Pathophysiology

Session: Miscellaneous clinical studies in heart failure (2)

Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.

Event: ESC Congress 2024

Topic: Metabolism

Session: Adipose tissue and other metabolic interactions

Predicting post-operative atrial fibrillation after heart surgery: clinical profile and biomarkers

Event: ESC Congress 2023

Topic: Defining Types of Atrial Fibrillation

Session: Predictors for atrial fibrillation

Semaglutide effects on human epicardial and subcutaneous fat released exosomes, aortic endothelial cells and neutrophils

Event: ESC Congress 2023

Topic: Leukocytes, Inflammation, Immunity

Session: Inflammatory mechanisms in vascular disease

MUC-16, tumour and congestive heart failure marker, is expressed on epicardial mesothelial cells and is inversely associated with epicardial fat genesis

Event: ESC Congress 2023

Topic: Biomarkers

Session: Elucidating basic mechanisms in heart failure

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources